Endocrinology Archives - Page 7 of 7 - Corcept Therapeutics

Cortisol as a Marker for Increased Mortality in Patients with Incidental Adrenocortical Adenomas

November 10, 2014

Debono et al • 2014 • J Clin Endocrinol Metab.

A new therapeutic approach in the medical treatment of Cushing’s syndrome: glucocorticoid receptor blockade with mifepristone.

November 15, 2013

Fleseriu et al. • 2013 • Endocr Pract. 2013;19(2):313-26.

Mifepristone, a glucocorticoid receptor antagonist, produces clinical and metabolic benefits in patients with Cushing’s syndrome.

April 15, 2012

Fleseriu et al. • 2012 • J Clin Endocrinol Metab. 2012;97(6):2039-49.

Successful long-term treatment of refractory Cushing’s disease with high-dose mifepristone (RU 486).

August 15, 2001

Chu et al. • 2001 • J Clin Endocrinol Metab. 2001;86(8):3568-73.